Cannabidiol Promotes Adipogenesis of Human and Mouse Mesenchymal Stem Cells Via PPARγ by Inducing Lipogenesis but Not Lipolysis

Overview

Journal Biochem Pharmacol

Specialties Biochemistry
Pharmacology

Date 2022 Jan 13

PMID 35026188

Authors

Richard C Chang

Chloe S Thangavelu

Erika M Joloya

Angela Kuo

Zhuorui Li

Bruce Blumberg

Affiliations

Soon will be listed here.

Abstract

Cannabidiol (CBD) is a non-psychoactive phytocannabinoid found in the Cannabis sativa plant. Human exposure to CBD can be through recreational marijuana use, commercially available CBD-containing products, and medical treatments. Previous studies found that cannabidiol may activate the master regulator of adipogenesis, peroxisome proliferator activated receptor gamma (PPARγ). Here we investigated the effects of CBD on adipogenesis in human and mouse multipotent mesenchymal stromal stem cells (MSCs). We tested the effects of CBD on nuclear receptor activation and adipogenic potential to demonstrate the mechanism of CBD effects and employed the in vitro MSC differentiation models to assess adipogenic effects of CBD.Using transient transfection assays, we demonstrated that CBD activated mouse and human PPARγ, but not its heterodimeric partner, the retinoid 'X' receptor, RXR. Our results showed that CBD increased lipid accumulation and the expression of adipogenic genes in mouse and human MSCs in vitro. Adipogenic differentiation induced by CBD was significantly decreased by the PPARγ antagonist T0070907, supporting the hypothesis that CBD promoted differentiation via PPARγ. Taken together, our results indicate that in humans and in mice, CBD induced adipogenic differentiation in MSCs through a PPARγ-dependent mechanism.

Citing Articles

Cannabidiol reshapes the gut microbiome to promote endurance exercise in mice.

Chen S, Lee Y, Song M, Lim C, Cho H, Shim H Exp Mol Med. 2025; 57(2):489-500.

PMID: 39966566 PMC: 11873264. DOI: 10.1038/s12276-025-01404-5.

Cannabidiol suppresses proliferation and induces cell death, autophagy and senescence in human cholangiocarcinoma cells via the PI3K/AKT/mTOR pathway.

Pongking T, Intuyod K, Thongpon P, Thanan R, Sitthirach C, Chaidee A J Tradit Complement Med. 2025; 14(6):622-634.

PMID: 39850601 PMC: 11752120. DOI: 10.1016/j.jtcme.2024.04.007.

Cannabidiol effects in stem cells: A systematic review.

Mesas C, Moreno J, Doello K, Pena M, Lopez-Romero J, Prados J Biofactors. 2024; 51(1):e2148.

PMID: 39653426 PMC: 11681305. DOI: 10.1002/biof.2148.

Tributyltin Enhances Macrophage Inflammation and Lipolysis, Contributing to Adipose Tissue Dysfunction.

Chang R, Whitlock R, Joloya E, To K, Huang Y, Blumberg B J Endocr Soc. 2024; 8(12):bvae187.

PMID: 39502475 PMC: 11535727. DOI: 10.1210/jendso/bvae187.

The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut.

Brown K, Funk K, Figueroa Barrientos A, Bailey A, Shrader S, Feng W Cells. 2024; 13(19.

PMID: 39404382 PMC: 11475737. DOI: 10.3390/cells13191618.

References

Zuardi A, Crippa J, Hallak J, Moreira F, Guimaraes F . Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res. 2006; 39(4):421-9. DOI: 10.1590/s0100-879x2006000400001. View

Ibeas Bih C, Chen T, Nunn A, Bazelot M, Dallas M, Whalley B . Molecular Targets of Cannabidiol in Neurological Disorders. Neurotherapeutics. 2015; 12(4):699-730. PMC: 4604182. DOI: 10.1007/s13311-015-0377-3. View

Pacifici R, Pichini S, Pellegrini M, Rotolo M, Giorgetti R, Tagliabracci A . THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis". Clin Chem Lab Med. 2019; 58(5):682-689. DOI: 10.1515/cclm-2019-0119. View

Chamorro-Garcia R, Shoucri B, Willner S, Kach H, Janesick A, Blumberg B . Effects of Perinatal Exposure to Dibutyltin Chloride on Fat and Glucose Metabolism in Mice, and Molecular Mechanisms, . Environ Health Perspect. 2018; 126(5):057006. PMC: 6072003. DOI: 10.1289/EHP3030. View

Sonego A, Prado D, Vale G, Sepulveda-Diaz J, Cunha T, Tirapelli C . Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors. Brain Behav Immun. 2018; 74:241-251. DOI: 10.1016/j.bbi.2018.09.014. View

Pazos M, Mohammed N, Lafuente H, Santos M, Martinez-Pinilla E, Moreno E . Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors. Neuropharmacology. 2013; 71:282-91. DOI: 10.1016/j.neuropharm.2013.03.027. View

Rangwala S, Lazar M . Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci. 2004; 25(6):331-6. DOI: 10.1016/j.tips.2004.03.012. View

OSullivan S, Sun Y, Bennett A, Randall M, Kendall D . Time-dependent vascular actions of cannabidiol in the rat aorta. Eur J Pharmacol. 2009; 612(1-3):61-8. DOI: 10.1016/j.ejphar.2009.03.010. View

Russo E, Guy G . A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2005; 66(2):234-46. DOI: 10.1016/j.mehy.2005.08.026. View

10.

Esposito G, Scuderi C, Valenza M, Togna G, Latina V, De Filippis D . Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement. PLoS One. 2011; 6(12):e28668. PMC: 3230631. DOI: 10.1371/journal.pone.0028668. View

11.

Keller P, Petrie J, De Rose P, Gerin I, Wright W, Chiang S . Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem. 2008; 283(21):14355-65. PMC: 2386939. DOI: 10.1074/jbc.M708323200. View

12.

le Maire A, Grimaldi M, Roecklin D, Dagnino S, Vivat-Hannah V, Balaguer P . Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Rep. 2009; 10(4):367-73. PMC: 2672886. DOI: 10.1038/embor.2009.8. View

13.

Rockwell C, Snider N, Thompson J, Vanden Heuvel J, Kaminski N . Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. Mol Pharmacol. 2006; 70(1):101-11. DOI: 10.1124/mol.105.019117. View

14.

Fellous T, De Maio F, Kalkan H, Carannante B, Boccella S, Petrosino S . Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets. Biochem Pharmacol. 2020; 175:113859. DOI: 10.1016/j.bcp.2020.113859. View

15.

Shoucri B, Hung V, Chamorro-Garcia R, Shioda T, Blumberg B . Retinoid X Receptor Activation During Adipogenesis of Female Mesenchymal Stem Cells Programs a Dysfunctional Adipocyte. Endocrinology. 2018; 159(8):2863-2883. PMC: 6669823. DOI: 10.1210/en.2018-00056. View

16.

Hind W, England T, OSullivan S . Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors. Br J Pharmacol. 2015; 173(5):815-25. PMC: 4761095. DOI: 10.1111/bph.13368. View

17.

Schwarz J, Neese R, Turner S, Dare D, Hellerstein M . Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest. 1995; 96(6):2735-43. PMC: 185982. DOI: 10.1172/JCI118342. View

18.

Vallee A, Lecarpentier Y, Guillevin R, Vallee J . Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease. Acta Biochim Biophys Sin (Shanghai). 2017; 49(10):853-866. DOI: 10.1093/abbs/gmx073. View

19.

Forman B, Umesono K, Chen J, Evans R . Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 1995; 81(4):541-50. DOI: 10.1016/0092-8674(95)90075-6. View

20.

Jung T, Hudson R, Rushlow W, Laviolette S . Functional interactions between cannabinoids, omega-3 fatty acids, and peroxisome proliferator-activated receptors: Implications for mental health pharmacotherapies. Eur J Neurosci. 2020; 55(4):1088-1100. DOI: 10.1111/ejn.15023. View